New Tor­rent Phar­ma­ceu­ti­cals Form 483 high­lights clean­ing and oth­er qual­i­ty is­sues

In­di­an drug­mak­er Tor­rent Phar­ma­ceu­ti­cals, which has pulled in about $1 bil­lion in 2022 rev­enue, is the lat­est In­di­an man­u­fac­tur­er to find it­self un­der the FDA …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER